Latest market price
38.90
-0.01-0.03%
OverviewShort InterestFilings
EWTXQT88Edgewise Therapeutics, Inc.·NASDAQ
38.90-0.03%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 02, 20264Statement of changes in beneficial ownership
Aug 17, 20264/AStatement of changes in beneficial ownership (amended)
Aug 17, 20264/AStatement of changes in beneficial ownership (amended)
Aug 17, 20264/AStatement of changes in beneficial ownership (amended)
Aug 17, 20264/AStatement of changes in beneficial ownership (amended)
Aug 17, 20264/AStatement of changes in beneficial ownership (amended)
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Aug 06, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 20264Statement of changes in beneficial ownership
Jul 16, 20268-K/ACurrent report (amended)
Jul 13, 20268-KCurrent report
Jul 02, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
#1 / 25 of 366
Page
▼
/ 15